Key result
Repeated exchange of degassed assay solution maintains high-quality in vitro actomyosin motility for over 8 hours.
Why the study?
In lab-on-a-chip applications of the in vitro motility assay, prolonged myosin function and the ability to repeatedly exchange solutions without functional deterioration are critical.
An optimized protocol for in vitro motility assays allows for prolonged actomyosin function over 8 hours, facilitating sustainable lab-on-a-chip applications.
Enables longer in vitro motility assays for research; leaves open any clinical cardiovascular translation.
In the in vitro motility assay (IVMA), actin filaments are observed while propelled by surface-adsorbed myosin motor fragments such as heavy meromyosin (HMM). In addition to fundamental studies, the IVMA is the basis for a range of lab-on-a-chip applications, e.g. transport of cargoes in nanofabricated channels in nanoseparation/biosensing or the solution of combinatorial mathematical problems in network-based biocomputation. In these applications, prolonged myosin function is critical as is the potential to repeatedly exchange experimental solutions without functional deterioration. We here elucidate key factors of importance in these regards. Our findings support a hypothesis that early deterioration in the IVMA is primarily due to oxygen entrance into in vitro motility assay flow cells. In the presence of a typically used oxygen scavenger mixture (glucose oxidase, glucose, and catalase), this leads to pH reduction by a glucose oxidase-catalyzed reaction between glucose and oxygen but also contributes to functional deterioration by other mechanisms. Our studies further demonstrate challenges associated with evaporation and loss of actin filaments with time. However, over 8 h at 21-26 °C, there is no significant surface desorption or denaturation of HMM if solutions are exchanged manually every 30 min. We arrive at an optimized protocol with repeated exchange of carefully degassed assay solution of 45 mM ionic strength, at 30 min intervals. This is sufficient to maintain the high-quality function in an IVMA over 8 h at 21-26 °C, provided that fresh actin filaments are re-supplied in connection with each assay solution exchange. Finally, we demonstrate adaptation to a microfluidic platform and identify challenges that remain to be solved for real lab-on-a-chip applications.
No takes yet. Share an insight, caveat, or question.
Melbacke et al. (2024) studied this question. Repeated exchange of degassed assay solution vs. Open flow cells without exchange was evaluated on Maintenance of high-quality motility (velocity and fraction of motile filaments). Repeated exchange of carefully degassed assay solution at 30-minute intervals maintained high-quality actomyosin motility in vitro for over 8 hours.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: